Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China flag China · Delayed Price · Currency is CNY
2.800
+0.010 (0.36%)
Nov 6, 2026, 2:14 PM CST

SHA:600165 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-30.4-90.38-538.91-464.71-141.48-166.09
Depreciation & Amortization
127.78127.78127.44137.85122.8459.85
Other Amortization
1.271.271.161.120.850.87
Loss (Gain) From Sale of Assets
-3.66-3.660.95-0.210.06-2.1
Asset Writedown & Restructuring Costs
111.37111.37107.99185.0723.66-
Loss (Gain) From Sale of Investments
-340.99-340.9983.26-34.18-34.96-39.77
Provision & Write-off of Bad Debts
2.992.990.21-1.160.12-0.27
Other Operating Activities
-34.3466.66184.1127.0891.0764.25
Change in Accounts Receivable
-45.68-45.68-18.01-25.44-16.694.58
Change in Inventory
-50.31-50.31-1.735.3360.58-121.37
Change in Accounts Payable
-153.71-153.71-24.1560.37-54.5181.53
Change in Other Net Operating Assets
-0.64-0.64-5.52.32-1.12-
Operating Cash Flow
-414.42-373.4-85.1923.1553.14-17.93
Operating Cash Flow Growth
----56.43%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-287.94-271.17-6.2-57.68-59.31-240.39
Sale of Property, Plant & Equipment
1.181.141.444.21-2.6
Cash Acquisitions
----2.21-498-32
Divestitures
-----250.07
Investment in Securities
-5.22---14.1114.11
Investing Cash Flow
-291.99-270.03-4.76-55.68-543.2-5.61

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-32764.25275.361,426729.6
Total Debt Issued
5332764.25275.361,426729.6
Long-Term Debt Repaid
--420.45-61.76-248.4-929.07-746.06
Lease Payments
-1.59-1.59-0.09---0.44
Total Debt Repaid
-386.16-420.45-61.76-248.4-929.07-746.06
Net Debt Issued (Repaid)
-333.16-93.452.4926.96496.53-16.46
Issuance of Common Stock
1,2411,241----
Common Dividends Paid
-10.43-1.69-3.65-23.25-53.14-55.29
Other Financing Activities
-103.55-52.0476.727.99--
Financing Cash Flow
794.181,09475.5611.7443.39-71.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.070.20.750.552.53-0.69
Net Cash Flow
87.7450.91-13.64-20.28-44.13-95.98

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-702.37-644.57-91.39-34.53-6.17-258.32
Free Cash Flow Growth
------
Free Cash Flow Margin
-133.04%-145.02%-26.47%-12.09%-0.91%-103.86%
Free Cash Flow Per Share
-0.30-0.40-0.13-0.05-0.01-0.38
Levered Free Cash Flow
-1,610-1,432168.4642.4364.392.8
Unlevered Free Cash Flow
-1,607-1,415259.31131.51121.8122.35
Free Cash Flow After Leases
-703.95-646.15-91.48-34.53-6.17-258.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
29.4827.2112.559.8-21.6619.73
Change in Working Capital
-248.44-248.44-51.472.3-9.0165.33